drugset / Trial / NCT01219673

Symptom Burden in Head and Neck Cancer

NCT01219673

RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this clinical research study is to compare armodafinil, bupropion, and minocycline when given alone or in combination. Researchers want to learn about the safety and level of effectiveness of these drugs in controlling symptoms, such as the side effects of chemoradiation, when given to patients with head and neck cancer.

Timeline

Start
2013-03
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Armodafinil Small molecule 150 mg Oral
Subject Bupropion Small molecule 100 mg Oral
Subject Minocycline Small molecule 100 mg

Indications